tirzepatide for heart failure with preserved ejection fraction and obesity Another "Positive" Trial that Falls Short SUMMIT Trial (1).pptx iowfnwoefwwofcewoc |

Something shifted

Patients with Long COVID continue to experience significant symptoms at 12 months and factors associated with improvement: A prospective cohort study in France (PERSICOR)

This may be especially important in lupus because lupus patients already have a higher risk of cardiovascular disease

Not everyone needs glutathione supplementation

What the broader data shows When researchers look beyond individual pancreatitis cases and analyze data from large clinical trials, the picture is reassuring

While GLP-1 medications may offer some health benefits for certain individuals when prescribed by and used under the guidance of a qualified health care provider, they also present new challenges for employer-sponsored health plans